FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 67 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,150,968 | -10.0% | 259,227 | -33.1% | 0.00% | – |
| Q2 2023 | $1,279,516 | +50.8% | 387,732 | +30.2% | 0.00% | – |
| Q1 2023 | $848,762 | -63.0% | 297,811 | -5.6% | 0.00% | -100.0% |
| Q4 2022 | $2,296,316 | -17.7% | 315,428 | -8.5% | 0.00% | 0.0% |
| Q3 2022 | $2,789,000 | +100.2% | 344,730 | +21.3% | 0.00% | – |
| Q2 2022 | $1,393,000 | -75.2% | 284,305 | +19.6% | 0.00% | -100.0% |
| Q1 2022 | $5,621,000 | +274.2% | 237,642 | +180.0% | 0.00% | – |
| Q4 2021 | $1,502,000 | -14.8% | 84,883 | +35.8% | 0.00% | – |
| Q3 2021 | $1,763,000 | +512.2% | 62,502 | +127.6% | 0.00% | – |
| Q2 2021 | $288,000 | +70.4% | 27,466 | +91.2% | 0.00% | – |
| Q1 2021 | $169,000 | -2.9% | 14,367 | -3.3% | 0.00% | – |
| Q4 2020 | $174,000 | -5.9% | 14,857 | -46.7% | 0.00% | – |
| Q3 2019 | $185,000 | – | 27,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |